Peter Olinga

8.8k citations
185 papers · 7.1k · 1 hit paper · h-index 45

Impact in

  • Hepatology top 0.5%
    • Liver physiology and pathology
  • Pharmacology top 0.2%
    • Pharmacogenetics and Drug Metabolism
    • Drug-Induced Hepatotoxicity and Protection

Papers in

    • Liver physiology and pathology 51
    • Liver Disease and Transplantation 10
    • Pharmacogenetics and Drug Metabolism 13
    • Drug-Induced Hepatotoxicity and Protection 13

Peter Olinga

182 papers receiving 6.9k citations

Peter Olinga's Hit Papers

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME 2013 · 1.0k citations
1.0k0+4+8Years since publication2505007501000

Peers

Peter Olinga
Comparison fields: 5 of 142
  • Hepatology 2.1k
  • Pharmacology 1.1k
  • Epidemiology 1.4k
  • Oncology 1.1k
  • Surgery 1.4k
Replace Gérard Feldmann with:
Gérard Feldmann France
Yoshiyuki Takei Japan
Klaas Poelstra Netherlands
Mark Α. Zern United States
Sanjeev Kumar Gupta United States
Bård H. Smedsrød Norway
Seung Kew Yoon South Korea
Mario Chojkier United States
Michal Heger Netherlands
A. Francavilla Italy
Peter Olinga relative to Gérard Feldmann France Gérard Feldmann's profile →
Citations per field
00.5×2×4×6.3×
Gérard Feldmann · 1×
Citations per year

Countries citing papers authored by Peter Olinga

Since Specialization
Citations

This map shows the geographic impact of Peter Olinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Olinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Olinga more than expected).

Fields of papers citing papers by Peter Olinga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Olinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Olinga. The network helps show where Peter Olinga may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Olinga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Olinga Line = papers co-authored together Peter Olinga links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Hit paper breakdown →
20131042
2 2010332
3 2000253
4 2018224
5 2004142
6 1999130
7 2007124
8 2018102
9 2001102
10 2013102
11 199799
12 199785
13 200185
14 201985
15 200584
16 200581
17 200781
18 201779
19 201578
20 200877

About Peter Olinga

Peter Olinga is a scholar working on Hepatology, Pharmacology, Epidemiology, Oncology and Nephrology, having authored 185 papers that have together received 7.1k indexed citations. Recurring topics across this work include Liver physiology and pathology (51 papers), Liver Disease Diagnosis and Treatment (34 papers), Drug Transport and Resistance Mechanisms (20 papers), Organ Transplantation Techniques and Outcomes (17 papers), Pharmacogenetics and Drug Metabolism (13 papers), Drug-Induced Hepatotoxicity and Protection (13 papers), Chronic Kidney Disease and Diabetes (11 papers) and Liver Disease and Transplantation (10 papers). The work is most often cited by research in Hepatology (2.1k citations), Pharmacology (1.1k citations), Epidemiology (1.4k citations), Oncology (1.1k citations) and Surgery (1.4k citations). Peter Olinga has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Geny M. M. Groothuis, Dirk K. F. Meijer, Marjolijn T. Merema, Henricus A. M. Mutsaers, Maarten J. H. Slooff, Dorenda Oosterhuis, Klaas Poelstra, Marina H. de Jager, Theerut Luangmonkong and Ruben de Kanter. Their work appears in journals such as Toxicology in Vitro, Journal of Hepatology, Frontiers in Medicine, Archives of Toxicology and Liver International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact